We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$9.35B
AUM Growth
+$149M
Cap. Flow
-$135M
Cap. Flow %
-1.45%
Top 10 Hldgs %
16.19%
Holding
2,678
New
110
Increased
434
Reduced
834
Closed
256

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$62.7M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$20.5M
3
DOW icon
Dow Inc
DOW
+$10.9M
4
ENB icon
Enbridge
ENB
+$8.91M
5
CTVA icon
Corteva
CTVA
+$5.55M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.4M
2
MUB icon
iShares National Muni Bond ETF
MUB
+$12.8M
3
DD icon
DuPont de Nemours
DD
+$10.6M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$8.73M
5
MSFT icon
Microsoft
MSFT
+$8.71M

Sector Composition

Rank Sector Weight
1 Technology 16.48%
2 Financials 14.84%
3 Healthcare 12.76%
4 Industrials 10.2%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CWEN.A
1876
DELISTED
Clearway Energy Class A
CWEN.A
$260K ﹤0.01%
16,087
– –
BANC icon
1877
Banc of California
BANC
$3.11B
$260K ﹤0.01%
18,620
– –
IBCP icon
1878
Independent Bank Corp
IBCP
$854M
$258K ﹤0.01%
11,863
– –
REGI
1879
DELISTED
Renewable Energy Group, Inc.
REGI
$258K ﹤0.01%
16,294
– –
RUBY
1880
DELISTED
Rubius Therapeutics, Inc
RUBY
$258K ﹤0.01%
16,410
– –
BV icon
1881
BrightView Holdings
BV
$1.08B
$258K ﹤0.01%
13,796
– –
NTLA icon
1882
Intellia Therapeutics
NTLA
$1.66B
$258K ﹤0.01%
15,741
– –
PGNX
1883
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$257K ﹤0.01%
41,699
+9,436
+29% +$45.5K
MYRG icon
1884
MYR Group
MYRG
$5.1B
$257K ﹤0.01%
6,874
– –
CRBP icon
1885
Corbus Pharmaceuticals
CRBP
$195M
$257K ﹤0.01%
1,235
+465
+60% +$99.6K
ETD icon
1886
Ethan Allen Interiors
ETD
$583M
$256K ﹤0.01%
12,159
– –
CARE icon
1887
Carter Bankshares
CARE
$757M
$255K ﹤0.01%
+12,904
New +$252K
ITCI
1888
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$254K ﹤0.01%
19,606
– –
DNR
1889
DELISTED
Denbury Resources, Inc.
DNR
$253K ﹤0.01%
204,313
– –
GME icon
1890
GameStop
GME
$8.33B
$253K ﹤0.01%
185,084
– –
TALO icon
1891
Talos Energy
TALO
$2.58B
$253K ﹤0.01%
10,507
– –
DHT icon
1892
DHT Holdings
DHT
$3.09B
$253K ﹤0.01%
42,744
– –
CTRL
1893
DELISTED
Control4 Corporation
CTRL
$252K ﹤0.01%
10,604
– –
STEL
1894
DELISTED
Stellar Bancorp
STEL
$252K ﹤0.01%
8,948
– –
FLWS icon
1895
1-800-Flowers.com
FLWS
$261M
$252K ﹤0.01%
13,330
– –
PGEN icon
1896
Precigen
PGEN
$2.32B
$251K ﹤0.01%
32,766
– –
TEN
1897
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$251K ﹤0.01%
22,605
– –
DX
1898
Dynex Capital
DX
$3.23B
$249K ﹤0.01%
14,895
+5,804
+64% +$102K
AGX icon
1899
Argan
AGX
$7.84B
$249K ﹤0.01%
6,140
– –
HUD
1900
DELISTED
Hudson Ltd. Class A Common Shares
HUD
$249K ﹤0.01%
18,056
– –
74 75
76
77 78

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

MetLife Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, MetLife Investment Management held 2,678 positions worth $9.35B, up 1.6% from $9.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management's Q2 2019 filing shows 110 new, 434 increased, 834 reduced and 256 closed positions. Its largest new stake was Dow Inc: 206,405 shares worth $10.2M. The largest sale was Apple, an estimated $13.4M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q2 2019 buy was Dow Inc: 206,405 shares worth $10.2M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $62.7M increase.
  • MetLife Investment Management's biggest Q2 2019 reduction was Apple, cutting an estimated $13.4M.
  • MetLife Investment Management fully exited iShares National Muni Bond ETF in Q2 2019, selling an estimated $12.8M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $9.35B portfolio in Q2 2019.
  • MetLife Investment Management opened 110 new positions and closed 256 in Q2 2019.
  • MetLife Investment Management's portfolio value rose 1.6% quarter-over-quarter to $9.35B.

Based on MetLife Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.